These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2410424)

  • 1. Structure and function of human C5a anaphylatoxin. Selective modification of tyrosine 23 alters biological activity but not antigenicity.
    Johnson RJ; Chenoweth DE
    J Biol Chem; 1985 Aug; 260(18):10339-45. PubMed ID: 2410424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Labeling the granulocyte C5a receptor with a unique photoreactive probe.
    Johnson RJ; Chenoweth DE
    J Biol Chem; 1985 Jun; 260(12):7161-4. PubMed ID: 3997863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemoattractant des-Arg74-C5a regulates the expression of its own receptor on a monocyte-like cell line.
    Barker MD; Jose PJ; Williams TJ; Burton DR
    Biochem J; 1986 Jun; 236(2):621-4. PubMed ID: 3019322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The properties of human C5a anaphylatoxin. The significance of C5a formation during hemodialysis.
    Chenoweth DE
    Contrib Nephrol; 1987; 59():51-71. PubMed ID: 3327650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an antigenic epitope and receptor binding domain of human C5a.
    Johnson RJ; Tamerius JD; Chenoweth DE
    J Immunol; 1987 Jun; 138(11):3856-62. PubMed ID: 2438329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of a new photoreactive C5a analog that permits identification of the ligand binding component of the granulocyte C5a receptor.
    Johnson RJ; Chenoweth DE
    Biochem Biophys Res Commun; 1987 Nov; 148(3):1330-7. PubMed ID: 3689398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.
    Gerard C; Hugli TE
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1833-7. PubMed ID: 6940191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the binding of fluorescent C5a and C3a to human peripheral blood leukocytes.
    van Epps DE; Chenoweth DE
    J Immunol; 1984 Jun; 132(6):2862-7. PubMed ID: 6373920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor activation by human C5a des Arg74 but not intact C5a is dependent on an interaction between Glu199 of the receptor and Lys68 of the ligand.
    Crass T; Bautsch W; Cain SA; Pease JE; Monk PN
    Biochemistry; 1999 Jul; 38(30):9712-7. PubMed ID: 10423250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-specific mutagenesis of residues in the human C5a anaphylatoxin which are involved in possible interaction with the C5a receptor.
    Bubeck P; Grötzinger J; Winkler M; Köhl J; Wollmer A; Klos A; Bautsch W
    Eur J Biochem; 1994 Feb; 219(3):897-904. PubMed ID: 8112341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PMN C5a-receptor down regulation is not involved in recovery from C5a-induced neutropenia.
    Gardinali M; Hugli TE; Ward DM; Agostoni A
    ASAIO Trans; 1987; 33(3):482-8. PubMed ID: 3499922
    [No Abstract]   [Full Text] [Related]  

  • 12. Mutation of glutamate 199 of the human C5a receptor defines a binding site for ligand distinct from the receptor N terminus.
    Monk PN; Barker MD; Partridge LJ; Pease JE
    J Biol Chem; 1995 Jul; 270(28):16625-9. PubMed ID: 7622471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity.
    Fick RB; Robbins RA; Squier SU; Schoderbek WE; Russ WD
    Pediatr Res; 1986 Dec; 20(12):1258-68. PubMed ID: 3540828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the interaction of human C5a and C5a des Arg with human monocytes and neutrophils: flow cytometric and chemotaxis studies.
    Yancey KB; Lawley TJ; Dersookian M; Harvath L
    J Invest Dermatol; 1989 Feb; 92(2):184-9. PubMed ID: 2493055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
    Oppermann M; Götze O
    Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C3, C5 components and C3a, C4a, and C5a fragments of the complement system.
    Janatova J
    Methods Enzymol; 1988; 162():579-625. PubMed ID: 3265757
    [No Abstract]   [Full Text] [Related]  

  • 17. Biochemistry and biology of anaphylatoxins.
    Hugli TE
    Complement; 1986; 3(3):111-27. PubMed ID: 3542363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A detailed analysis of the C5a anaphylatoxin effector domain: selection of C5a phage libraries on differentiated U937 cells.
    Hennecke M; Otto A; Baensch M; Kola A; Bautsch W; Klos A; Köhl J
    Eur J Biochem; 1998 Feb; 252(1):36-44. PubMed ID: 9523709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular receptors to the anaphylatoxins C3a and C5a.
    Huey R; Fukuoka Y; Hoeprich PD; Hugli TE
    Biochem Soc Symp; 1986; 51():69-81. PubMed ID: 3545212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric receptors of the human C3a receptor and C5a receptor (CD88).
    Crass T; Ames RS; Sarau HM; Tornetta MA; Foley JJ; Köhl J; Klos A; Bautsch W
    J Biol Chem; 1999 Mar; 274(13):8367-70. PubMed ID: 10085065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.